Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
23M
-
Shares change
-
+630K
-
Total reported value, excl. options
-
$489M
-
Value change
-
+$12.8M
-
Number of buys
-
37
-
Number of sells
-
-30
-
Price
-
$21.34
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q3 2015
76 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q3 2015.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23M shares
of 62.5M outstanding shares and own 36.72% of the company stock.
Largest 10 shareholders include Third Rock Ventures, LLC (7.39M shares), FMR LLC (4.07M shares), BVF INC/IL (1.7M shares), WELLINGTON MANAGEMENT GROUP LLP (1.27M shares), Partner Fund Management, L.P. (1.03M shares), Visium Asset Management, LP (1.02M shares), LORD, ABBETT & CO. LLC (643K shares), RS INVESTMENT MANAGEMENT CO LLC (630K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (587K shares), and CITADEL ADVISORS LLC (547K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.